Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_provenance.
- NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_assertion description "[In December 2014, a poly(ADP-ribose) polymerase (PARP) inhibitor was granted expedited approved by the United States Food and Drug Administration for use in advanced ovarian cancer patients with germline BRCA1/2 mutations who have received three or more prior lines of chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_provenance.
- NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_assertion evidence source_evidence_literature NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_provenance.
- NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_assertion SIO_000772 25725131 NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_provenance.
- NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_assertion wasDerivedFrom befree-2016 NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_provenance.
- NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_assertion wasGeneratedBy ECO_0000203 NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1266985.RAXYGkdXPRCPvCpYW_hSLS5doF-lYvm49Hvjepillx5gE130_provenance.